v3.24.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   162,444,717      
Beginning balance at Dec. 31, 2022 $ 697,616 $ 162 $ 855,249 $ (157,542) $ (253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock on exercise of stock options (in shares)   1,055,108      
Issuance of common stock on exercise of stock options 2,365 $ 1 2,364    
Vesting of restricted and performance-based restricted stock units (in shares)   802,576      
Vesting of restricted and performance-based restricted stock units 0 $ 1 (1)    
Repurchase of common stock (in shares)   (2,652,372)      
Repurchase of common stock (20,052) $ (2) (20,050)    
Stock-based compensation 15,127   15,127    
Other comprehensive income (loss) 197       197
Net income (loss) (13,706)     (13,706)  
Ending balance (in shares) at Mar. 31, 2023   161,650,029      
Ending balance at Mar. 31, 2023 681,547 $ 162 852,689 (171,248) (56)
Beginning balance (in shares) at Dec. 31, 2022   162,444,717      
Beginning balance at Dec. 31, 2022 697,616 $ 162 855,249 (157,542) (253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) (208)        
Net income (loss) (30,782)        
Ending balance (in shares) at Jun. 30, 2023   163,030,400      
Ending balance at Jun. 30, 2023 673,858 $ 163 862,480 (188,324) (461)
Beginning balance (in shares) at Mar. 31, 2023   161,650,029      
Beginning balance at Mar. 31, 2023 681,547 $ 162 852,689 (171,248) (56)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   253,973      
Issuance of common stock under the Employee Stock Purchase Plan 1,463   1,463    
Issuance of common stock on exercise of stock options (in shares)   1,528,955      
Issuance of common stock on exercise of stock options 3,098 $ 1 3,097    
Vesting of restricted and performance-based restricted stock units (in shares)   1,006,863      
Vesting of restricted and performance-based restricted stock units 0 $ 1 (1)    
Repurchase of common stock (in shares)   (1,409,420)      
Repurchase of common stock (10,047) $ (1) (10,046)    
Stock-based compensation 15,278   15,278    
Other comprehensive income (loss) (405)       (405)
Net income (loss) (17,076)     (17,076)  
Ending balance (in shares) at Jun. 30, 2023   163,030,400      
Ending balance at Jun. 30, 2023 673,858 $ 163 862,480 (188,324) (461)
Beginning balance (in shares) at Dec. 31, 2023   163,361,513      
Beginning balance at Dec. 31, 2023 651,471 $ 163 867,152 (215,829) (15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock on exercise of stock options (in shares)   469,841      
Issuance of common stock on exercise of stock options 1,145 $ 1 1,144    
Vesting of restricted and performance-based restricted stock units (in shares)   812,602      
Vesting of restricted and performance-based restricted stock units 0 $ 1 (1)    
Repurchase of common stock (in shares)   (2,799,891)      
Repurchase of common stock (15,290) $ (3) (15,287)    
Stock-based compensation 11,602   11,602    
Other comprehensive income (loss) (129)       (129)
Net income (loss) (2,356)     (2,356)  
Ending balance (in shares) at Mar. 31, 2024   161,844,065      
Ending balance at Mar. 31, 2024 646,443 $ 162 864,610 (218,185) (144)
Beginning balance (in shares) at Dec. 31, 2023   163,361,513      
Beginning balance at Dec. 31, 2023 651,471 $ 163 867,152 (215,829) (15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) (146)        
Net income (loss) 3,373        
Ending balance (in shares) at Jun. 30, 2024   162,033,803      
Ending balance at Jun. 30, 2024 658,278 $ 162 870,733 (212,456) (161)
Beginning balance (in shares) at Mar. 31, 2024   161,844,065      
Beginning balance at Mar. 31, 2024 646,443 $ 162 864,610 (218,185) (144)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   262,237      
Issuance of common stock under the Employee Stock Purchase Plan 1,016   1,016    
Issuance of common stock on exercise of stock options (in shares)   330,894      
Issuance of common stock on exercise of stock options 727 $ 0 727    
Vesting of restricted and performance-based restricted stock units (in shares)   970,715      
Vesting of restricted and performance-based restricted stock units 0 $ 1 (1)    
Repurchase of common stock (in shares)   (1,374,108)      
Repurchase of common stock (6,891) $ (1) (6,890)    
Stock-based compensation 11,271   11,271    
Other comprehensive income (loss) (17)       (17)
Net income (loss) 5,729     5,729  
Ending balance (in shares) at Jun. 30, 2024   162,033,803      
Ending balance at Jun. 30, 2024 $ 658,278 $ 162 $ 870,733 $ (212,456) $ (161)